Skip to main content

Table 5 Gene model validation test by discriminant analysis. Malignant or benign group allocation probability values for the unknown samples

From: The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management

Unknown samples

Benign probability

Malignant probability

Predicted diagnosis

Cytological diagnosis

Pathological diagnosis

BRAF status

A

0.0700

0.9300

Malignant

SPTC

Malignant

V600E

B

0.0530

0.9470

Malignant

SPTC

Malignant

V600E

C

0.1075

0.8925

Malignant

SPTC

Malignant

V600E

D

0.0177

0.9823

Malignant

SPTC

Malignant

V600E

E

0.1964

0.8036

Malignant

SPTC

Malignant

V600E

F

0.1380

0.8620

Malignant

SPTC

Malignant

V600E

G

0.0935

0.9065

Malignant

SPTC

Malignant

WT

H

0.1369

0.8631

Malignant

SPTC

Malignant

WT

I

0.1458

0.8542

Malignant

SPTC

Malignant

V600E

L

0.2110

0.7890

Malignant

SPTC

Malignant

WT

M

0.0415

0.9585

Malignant

SPTC

Malignant

WT